SPONSOR
Nanfang Hospital, Southern Medical University
Total Trials
11
Recruiting
11
Phases
Phase 2
Conditions studied: Esophageal Squamous Cell CarcinomaIntrahepatic CholangiocarcinomaLiver FailureLiver DysfunctionCRC (Colorectal Cancer)Lung Cancer (Diagnosis)Acute Graft-versus-Host DiseaseHematopoietic Stem Cell TransplantationSmall Cell Lung Cancer Extensive StageRadiation-induced Oropharyngeal Mucositis
Nanfang Hospital, Southern Medical University is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Esophageal Squamous Cell Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Failure, Liver Dysfunction.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Nanfang Hospital, Southern Medical University
How many clinical trials has Nanfang Hospital, Southern Medical University sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by Nanfang Hospital, Southern Medical University, of which 11 are actively recruiting participants. These trials cover conditions including Esophageal Squamous Cell Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Failure. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Nanfang Hospital, Southern Medical University research focus on?
Nanfang Hospital, Southern Medical University clinical trials span Esophageal Squamous Cell Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Failure, Liver Dysfunction, CRC (Colorectal Cancer), and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Nanfang Hospital, Southern Medical University clinical trial?
To participate in a Nanfang Hospital, Southern Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Nanfang Hospital, Southern Medical University trials with current recruitment status updated daily.
Clinical Trials by Nanfang Hospital, Southern Medical University
NCT06885814 Phase 2
Recruiting
Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
NCT06298968 Phase 2
Recruiting
Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
NCT06532214
Recruiting
Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy
Liver Failure
NCT07239063
Recruiting
Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer
CRC (Colorectal Cancer)
NCT06708507
Recruiting
Tissue-resident Immune Cell Subsets in aGVHD
Acute Graft-versus-Host Disease
NCT06429696 Phase 2
Recruiting
PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
Small Cell Lung Cancer Extensive Stage
NCT06308328
Recruiting
A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis
Radiation-induced Oropharyngeal Mucositis
NCT07622667
Recruiting
Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis
Malignant Tumors
NCT06952387
Recruiting
PeRsonalized Blood prEssure Management on Postoperative Complications and Mortality in hIgh-risk Patients Undergoing Major Non-cardiac Surgery
Hypotension
NCT07707076
Recruiting
Flow Diverter Versus Conventional Endovascular Treatment for Unruptured Wide-Neck Bifurcation Aneurysms (FD-BWA Trial)
Unruptured Intracranial Wide-neck Bifurcation Aneurysms
NCT07608120
Recruiting
Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation
Colonoscopy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology